Redefining Rare Genitourinary Cancers: An Initiative Led by the Global Society of Rare Genitourinary Tumors

Tiago Costa de Padua; Fernando Sabino Marques Monteiro; Andrea Necchi; Philippe E Spiess

doi:10.1016/j.eururo.2024.02.005

Redefining Rare Genitourinary Cancers: An Initiative Led by the Global Society of Rare Genitourinary Tumors

Eur Urol. 2024 May;85(5):414-416. doi: 10.1016/j.eururo.2024.02.005. Epub 2024 Feb 24.

Authors

Tiago Costa de Padua¹, Fernando Sabino Marques Monteiro², Andrea Necchi³, Philippe E Spiess⁴

Affiliations

¹ Department of Medical Oncology, IRCCS San Raffaele Hospital, Milano, Italy; Medical and Scientific Services, Hematology and Oncology Department, IQVIA, São Paulo, Brazil.
² Hospital Sírio-Libanês, Brasília, Brazil; Latin American Cooperative Oncology Group, Porto Alegre, Brazil.
³ Department of Medical Oncology, IRCCS San Raffaele Hospital, Milano, Italy; Vita-Salute San Raffaele University, Milan, Italy.
⁴ Department of Genitourinary Oncology, H. Lee Moffitt Cancer Center, Tampa, FL, USA. Electronic address: [email protected].

PMID: 38403526
DOI: 10.1016/j.eururo.2024.02.005

Abstract

Rare cancers account for 20-25% of all cancers diagnosed annually but there is no consensus on the definition of a rare cancer and substantial geographic heterogeneity. The Global Society of Rare Genitourinary Tumors is dedicated to education and research for rare genitourinary tumors.

Publication types

Editorial

MeSH terms

Consensus
Humans
Neoplasms*
Urogenital Neoplasms* / diagnosis
Urogenital Neoplasms* / pathology
Urogenital Neoplasms* / therapy